PGPEP1 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population, providing a loss-of-function model for the PGPEP1 gene in the Homo sapiens Raji B lymphoblast cell line. The polyclonal population, generated via CRISPR/Cas9-mediated gene disruption, offers a heterogeneous knockout pool, facilitating studies of PGPEP1 function without clonal selection. This product is designed for researchers investigating neuropeptide processing and peptide hormone metabolism.
The Raji cell line is an EBV-positive Burkitt??s lymphoma-derived B lymphoblast, extensively used to model B cell biology and adaptive immune responses. Raji cells exhibit robust immunoglobulin production and are a well-established platform for examining signaling pathways intersecting with peptide hormone regulation. The integration of PGPEP1 knockout in this background enables exploration of how neuropeptide processing influences B cell function.
PGPEP1 encodes a pyroglutamyl aminopeptidase that catalyzes the removal of N-terminal pyroglutamyl residues from bioactive peptides, a critical step in maturation and inactivation. Key substrates include thyrotropin-releasing hormone (TRH), neurotensin, and gonadotropin-releasing hormone (GnRH). Enzymatic activity is influenced by upstream transcription factors such as SP1 and AP-1, and hormonal stimuli. PGPEP1 works in concert with prohormone convertases to generate mature peptides, which then activate cognate receptors and downstream signaling cascades. Disruption of PGPEP1 alters the repertoire of processed peptides, perturbing cellular signaling networks mediated by these neuropeptides.
In a B lymphoblast context, PGPEP1??s role in peptide processing may intersect with immune regulation. Whereas its primary characterized functions are in neuroendocrine tissues, the presence of neuropeptide receptors on immune cells suggests autocrine or paracrine modulation. This knockout model allows the dissection of PGPEP1-dependent peptide metabolism within an immune environment, potentially revealing implications for neuro-immune crosstalk and the modulation of adaptive immunity. Although no definitive disease association is established, alterations in PGPEP1 have been implicated in neurological disorders, and this cell model provides a simplified system to study its biochemistry.
The PGPEP1 Knockout Raji Polyclonal Cells are ideal for neuropeptide processing studies and enzyme kinetics characterization. Researchers can employ fluorogenic substrate assays to measure pyroglutamyl aminopeptidase activity directly, western blotting and RT-qPCR to assess gene and protein expression changes, immunofluorescence for subcellular localization, and mass spectrometry for global peptide profiling. This tool supports biomarker discovery efforts and high-throughput screening for modulators of peptide hormone pathways. For additional information, including availability and pricing, please contact Ascent Research.
